Full Text View
Tabular View
Study Results
Related Studies
Efficacy Study Measuring the Impact of Pregabalin on Peripheral Neuropathic Pain.
This study has been completed.
Study NCT00219544   Information provided by Pfizer

First Received on September 13, 2005.   Last Updated on April 22, 2011   History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Neuropathic Pain
Additional conditions recognized in this trial
Neuralgia
More general conditions related to this trial
Nervous System Diseases
Neurologic Manifestations
Neuromuscular Diseases
Pain
Peripheral Nervous System Diseases
Signs and Symptoms
Interventions listed in this trial
Pregabalin (Lyrica)
Placebo
Additional drug interventions recognized in this trial
Pregabalin
More general drug interventions related to this trial
Analgesics
Anticonvulsants
Central Nervous System Agents
Peripheral Nervous System Agents
Pharmacologic Actions
Physiological Effects of Drugs
Sensory System Agents
Therapeutic Uses
Sponsors listed in this trial
Pfizer


Contact Help Desk
Lister Hill National Center for Biomedical Communications,  U.S. National Library of Medicine,
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services